Brexit: What Now For Device Notified Bodies, CE Marks And The Future MDR/IVDR?
This article was originally published in SRA
Executive Summary
While the UK and the EU struggle to comprehend the full implications of the UK's decision to leave the EU, Amanda Maxwell considers the implications for the implementation of the future EU regulations on medical devices and IVDs, including the question mark that hangs over the future of UK notified bodies.
You may also be interested in...
Is The UK Still Open For Medtech Innovation And Reimbursement?
Confusing and ineffective channels of innovation adoption and a lack of funding hamper the UK's reputation as one of the world's health care capitals and a driver of care excellence – in spite of its global brands, NICE, MHRA and the NHS itself. But changes that should transform market access are in place and are worthy of close attention in the next two to three years.
Q&A With Nadim Yared: AdvaMed's Next Chair On Capital Formation And Global Challenges
Nadim Yared is set to become the first small-company CEO ever to chair AdvaMed's board of directors in March. The CVRx executive spoke to Medtech Insight about what that means, the challenge of raising funds in medtech, and AdvaMed's role in the current political environment in the US and abroad.
Swiss Medtech Voices Brexit Business Fears, Prepares For EU Regs
Switzerland is small in geographic terms, but a major player in medtech. It has been among the first to detail its economic concerns tied to the UK's plans to leave the European Union.